asa glp 1 agonists Holding GLP-1 Prior to Elective Procedures 2025 ADS/ANZCA/GESA/NACOS clinical practice recommendations
Description
Multiple sclerosis GLP-1 receptor agonists show neuroprotective properties that extend to autoimmune conditions of the central nervous system
Proposed mechanisms include reduced postprandial glucose excursions, potentially through delayed glucose absorption and modest increases in endogenous GLP-1 secretion, though human evidence remains limited and of low certainty
It is a powerful triple-threat metabolic peptide for weight loss and obesity management
He called it Exendin-4
Decoding alzheimers disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies
Conversely, blocking the Notch signal leads to the expression of Atoh1 , which induces secretory progenitors [20]
